Synovus Financial (SNV)
(Delayed Data from NYSE)
$42.53 USD
+0.04 (0.09%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $42.54 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$42.53 USD
+0.04 (0.09%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $42.54 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Zacks News
FITB Gives Q3 Update, Commercial Payment to Reach $1B in 5 Years
by Zacks Equity Research
Fifth Third updates its third-quarter 2024 guidance while focusing on enhancing its commercial payment platform through strategic partnerships.
Huntington's Strategic Initiatives Look Promising: Is the Stock a Buy?
by Zacks Equity Research
HBAN is progressing well with its strategic initiatives to expand into high-growth markets to boost its loans and deposit balances.
Synovus Stock Falls 2.1%, Fed Rate Cut to Hurt Q3 NII Growth
by Zacks Equity Research
SNV provides its third-quarter 2024 outlook. NII is expected to be impacted by the muted loan growth environment and the impact of expected Federal Reserve rate cuts.
Synovus (SNV) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Synovus (SNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
5 Reasons to Add Synovus (SNV) Stock to Your Portfolio Now
by Zacks Equity Research
Synovus (SNV) is well poised to gain from strategic mergers and acquisitions and balance sheet strength.
Why Is Synovus (SNV) Down 4.7% Since Last Earnings Report?
by Zacks Equity Research
Synovus (SNV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synovus (SNV) Thrives on Organic Growth Amid High Costs
by Zacks Equity Research
Synovus (SNV) continues to benefit from strong loans and deposit balances. Balance sheet strength and strong liquidity position is another positive.
Synovus Financial (SNV) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Synovus Financial (SNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is First Trust SMID Cap Rising Dividend Achievers ETF (SDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SDVY
Capital One (COF) Q2 Earnings Miss on Y/Y Increase in Provisions
by Zacks Equity Research
Capital One (COF) records y/y increases in revenues and expenses in the second quarter of 2024.
Synovus (SNV) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Synovus' (SNV) Q2 earnings benefit from a year-over-year decline in expenses and provisions. However, declining loan and deposit balances, along with lower NII, act as spoilsports.
Synovus (SNV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Synovus (SNV) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Synovus Financial (SNV) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of 20.83% and 38.35%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What Makes Synovus Financial (SNV) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Synovus Financial (SNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ahead of Synovus (SNV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Synovus (SNV) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Earnings Preview: Investar (ISTR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Investar (ISTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Synovus Financial (SNV) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus' (SNV) Organic Expansion Drives Growth, High Costs Ail
by Zacks Equity Research
Synovus (SNV) benefits from the strategic expansion efforts of its banking verticals. However, a rise in expenses is likely to impede bottom-line growth in the near term.
Synovus (SNV) Arm Ratings Affirmed by Moody's, Outlook Stable
by Zacks Equity Research
Moody's rating affirms Synovus' (SNV) subsidiary's ratings with a stable outlook. This shows a balance between the credit headwinds associated with a significant concentration in CRE loans.
Synovus (SNV) to Sell RWA & Reposition Securities Portfolio
by Zacks Equity Research
Synovus (SNV) plans to reduce risk-weighted assets by $2-$2.4 billion in second-quarter 2024 and sell available-for-sale securities with a book value of $1.6 billion.
Synovus (SNV) Q1 Earnings & Revenues Miss, Expenses Rise Y/Y
by Zacks Equity Research
Synovus' (SNV) Q1 results reflect y/y declines in revenues and loan balances, as well as increased expenses and provisions.
Compared to Estimates, Synovus (SNV) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Synovus (SNV) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synovus Financial (SNV) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of -20.20% and 2.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Unveiling Synovus (SNV) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Synovus (SNV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Hilltop Holdings (HTH) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Hilltop Holdings (HTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.